FMP

FMP

Enter

CODX - Co-Diagnostics,...

photo-url-https://financialmodelingprep.com/image-stock/CODX.png

Co-Diagnostics, Inc.

CODX

NASDAQ

Co-Diagnostics, Inc., a molecular diagnostics company, develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally. It offers polymerase chain reaction (PCR) diagnostic tests for COVID-19, tuberculosis, hepatitis B and C, human papilloma virus, malaria, chikungunya, dengue, and the zika virus; three multiplexed tests to test mosquitos for the identification of diseases carried by the mosquitos; and molecular tools for detection of infectious diseases, liquid biopsy for cancer screening, and agricultural applications. The company also provides tests that identify genetic traits in plant and animal genomes; and portable PCR device designed to bring PCR to patients in point-of-care and at-home settings. In addition, it intends to sell diagnostic equipment from other manufacturers as self-contained lab systems. The company was incorporated in 2013 and is headquartered in Salt Lake City, Utah.

1.32 USD

0.07 (5.3%)

About

ceo

Mr. Dwight H. Egan

sector

Healthcare

industry

Medical - Devices

exchange

NASDAQ

Description

Co-Diagnostics, Inc., a molecular diagnostics company, develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally. It offers polymerase chain reaction (PCR) diagnostic tests for COVID-19, tuberculosis, hepatitis B and C, human papilloma virus, malaria, chikungunya, dengue, and the zika virus; three multiplexed tests to test mosquitos for the identification of diseases carried by the mosquitos; and molecular tools for detection of infectious diseases, liquid biopsy for cancer screening, and agricultural applications. The company also provides tests that identify gen...

CIK

0001692415

ISIN

US1897631057

CUSIP

189763105

Address

2401 South Foothill Drive

Phone

801 438 1036

Country

US

Employee

155

IPO Date

Jul 12, 2017

CODX Financial Summary

CIK

0001692415

Exchange

NASDAQ

Industry

Medical - Devices

Sector

Healthcare

CUSIP

189763105

ISIN

US1897631057

Country

US

Price

1.32

Beta

-0.87

Volume Avg.

246.47k

Market Cap

42.12M

Shares

-

52-Week

1.0-2.23

DCF

-0.01

ROE

-

ROA

-

Operating Margin

-

Debt/Equity

-

P/E

-1.05

P/B

-

Website

https://www.codiagnostics.com

Historical Prices

We are unable to load the chart at this time.

fmp-logo

Financial Statement

We are unable to load the chart at this time.

fmp-logo

Earnings

We are unable to load the chart at this time.

fmp-logo

Upgrades and Downgrades

We are unable to load this data!

fmp-logo

People Also Watch

page loading card

Latest CODX News

It looks like there's no news available.

fmp-logo
FMP

FMP

Financial Modeling Prep API provides real time stock price, company financial statements, major index prices, stock historical data, forex real time rate and cryptocurrencies. Financial Modeling Prep stock price API is in real time, the company reports can be found in quarter or annual format, and goes back 30 years in history.
twitterlinkedinfacebookinstagram
2017-2024 © Financial Modeling Prep